Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Infectious Disease
•
General Infectious Disease
What is your recommendation for timing of urgent chemotherapy in patients with staph aureus bacteremia or endocarditis who require prolonged durations?
Related Questions
Would you recommend using a rectal swab for C difficile testing in an inpatient with diarrhea if nurses have been unable to collect a stool sample for 24 hours due to the patient not cooperating with collection?
Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?
Do you preferentially avoid use of piperacillin-tazobactam for empiric anti-pseudomonal coverage in hospitalized patients due to risk of nephrotoxicity?
Do you ever favor cefazolin over ceftriaxone for bacteremia with susceptible E. coli?
Do you give chronic antibiotic prophylaxis for recurrent UTIs, including Pseudomonas aeruginosa, in a patient with retained ureteral stents?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
Is there any utility to trending Histoplasma serology titers to guide duration of therapy or treatment response for pulmonary histoplasmosis with negative urine antigen?
Do you recommend, based on current evidence, avoiding antimotility agents in patients with non-fulminant C. difficile infection who have no evidence of ileus?
What is your preferred agent and duration to treat an epidural abscess due to azole-resistant candida species?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
